Use of clindamycin before dental procedure in immunocompromised patients – case report
Izabela Strużycka1 | Agnieszka Bogusławska-Kapała1 | Przemysław Orzechowski2 | Beata Sulik-Tyszka3 | Justyna Cieślik3 | Marta Wróblewska3, 4
Use of clindamycin before dental procedure in immunocompromised patients – case report
Izabela Strużycka1 | Agnieszka Bogusławska-Kapała1 | Przemysław Orzechowski2 | Beata Sulik-Tyszka3 | Justyna Cieślik3 | Marta Wróblewska3, 4
Prevention of vertical transmission of HIV from the perspective of the gynecologist
Agnieszka Wroblewska | Justyna D. Kowalska
Risk factors related to the recognition and prevention of healthcare-associated infections
Anna Ziółko
Symptomatic uncomplicated diverticular disease of the colon – the current state of knowledge and principles of treatment
Maria Kłopocka | Ariel Liebert
Use of clindamycin in therapy of oral cavity infections
Beata Sulik-Tyszka1 | Justyna Cieślik1 | Agnieszka Bogusławska-Kapała2 | Izabela Strużycka2 | Marta Wróblewska1, 3
Fidaxomycin in the treatment of Clostridium difficile infection
Grażyna Rydzewska1, 2
Antifungal activity of selected anticancer drugs
Jakub Król1 | Urszula Nawrot2 | Marzenna Bartoszewicz2
Management of invasive fungal infections in the critically ill non-neutropenic patients – recent recommendations
Mirosław Czuczwar1 | Jolanta Komarnicka2 | Jarosław Woroń3, 4 | Wiktor Sułkowski5 | Alicja Bartkowska-Śniatkowska6
Presence faecal lactoferrin in patients with Clostridium difficile infection – own observations
Marcin Hawro1 | Krzysztof Tomasiewicz2 | Robert Pleśniak1 | Marta Musz-Kawecka1